NIFTY NINE IN NINETY NINE PLUS ONE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (325)	2/1/1999 7:26:00 AM
From: Arthur Radley	Read Replies (2) of 613

I don't know. SCIOS will probably take a hit today even though they got a rec. for their heart drug on Friday. Local TV carried news about this new drug, but it appears that from the review panel they were not impressed with the potential for the drug. Today's WSJ has article today and it isn't upbeat. This weeks Business Week has a interesting article on cell transplants. Article mentions Diacin and Genzyme. What I found intriguing about the article was the info on the fact that even though the body will "try" to reject an organ transplant, the brain will not reject the implanting of cells there. I wonder why the immune system is so particular about a new kidney but will allow this to happen. Any ideas?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next